A Study to Measure the Sun Protection Factor (SPF) and Ultraviolet-A Protection Factor (UVAPF) of Four Developmental Sunscreen Formulations
NCT03157583 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 8
Last updated 2019-07-22
Summary
The purpose of this study is to determine the SPF and UVAPF of four sunscreen formulations using international standard methodologies ISO24444:2010 for SPF and ISO24443:2012 for UVAPF.
Conditions
- Sunscreening Agents
Interventions
- OTHER
-
NGBUV000A, (Expected SPF 30)
A total of 2.0 ± 0.05 mg/cm2 (milligram per centimeter square of test site area) NGBUV000A (test product 1) will be spread at the topical test sites on the back of each participant. And a total of 1.3 mg/cm2 of test product 1 will be applied to the test plates.
- OTHER
-
NGBUV000B, (Expected SPF 30)
A total of 2.0 ± 0.05 mg/cm2 NGBUV000B (test product 2) will be spread at the topical test sites on the back of each participant. And a total of 1.3 mg/cm2 of test product 2 will be applied to the test plates.
- OTHER
-
NGBUV000C, (Expected SPF 30)
A total of 2.0 ± 0.05 mg/cm2 NGBUV000C (test product 3) will be spread at the topical test sites on the back of each participant. And a total of 1.3 mg/cm2 of test product 3 will be applied to the test plates.
- OTHER
-
NGBUV000D, (Expected SPF 30)
A total of 2.0 ± 0.05 mg/cm2 NGBUV000D (test product 4) will be spread at the topical test sites on the back of each participant. And a total of 1.3 mg/cm2 of test product 4 will be applied to the test plates.
- OTHER
-
P3 Standard, (Expected SPF 16)
A total of 2.0 ± 0.05 mg/cm2 reference P3 standard will be spread at the topical test sites on the back of each participant.
- OTHER
-
Sunscreen formulation S2
A total of 1.3 mg/cm2 of sunscreen formulation S2 will be applied to the test plates.
- OTHER
-
Glycerin
A total of 1.3 mg/cm2 of glycerin will be applied to the test plates.
Sponsors & Collaborators
- lead INDUSTRY
Principal Investigators
-
GSK Clinical Trials · GlaxoSmithKline
-
GSK Clinical Trials · GlaxoSmithKline (for GlaxoSmithKline; Human Genome Sciences Inc., a GSK Company; Sirtris, a GSK Company; Stiefel, a GSK Company; ViiV Healthcare)
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- SINGLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 70 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2017-06-21
- Primary Completion
- 2017-07-07
- Completion
- 2017-07-07
Countries
- Germany
Study Locations
More Related Trials
-
Sunscreen Efficacy Against the Reccurence of Lesions Post-sun Exposure in Acneic Subjects
NCT05168397 ·Status: COMPLETED
-
Photoprotection Efficacy of Four Sunscreen Formulas Under Visible Light Exposure
NCT06796010 ·Status: COMPLETED
-
Evaluate the Photoprotection Efficiency of Sunscreen Formulas Under Visible Light Exposure
NCT06796088 ·Status: COMPLETED
-
18842 - Sun Protection Factor Assay
NCT02717325 ·Status: COMPLETED ·Phase: NA
-
Evaluation of a Gel Sunscreen in Controlled Use Conditions (208/2016)
NCT03012347 ·Status: COMPLETED ·Phase: NA
-
Dermal Penetration of the Titanium Dioxide in Anthelios SX SPF40 Cream
NCT01021787 ·Status: COMPLETED ·Phase: PHASE4
-
Evaluation of the Photoprotection Efficacy with Sunscreen Formulas Under Visible Light Exposure
NCT06803901 ·Status: COMPLETED
-
Determine the Photoprotection Efficacy of Seven Sunscreen Products Under Visible Light Exposure.
NCT06796179 ·Status: COMPLETED
-
Protective Effect Assessment of Foto Ultra Isdin Solar Allergy Fusion Fluid on the UVA Induced PLE
NCT05320315 ·Status: COMPLETED ·Phase: NA
-
Evaluation of the Photoprotection Efficacy of Three Sunscreen Products Under Visible Light Exposure.
NCT06796205 ·Status: COMPLETED
-
Evaluate the Photoprotection Efficacy of Sunscreen Formulas Under Visible Light Exposure
NCT06796192 ·Status: COMPLETED
-
Multiday Beach Study
NCT03041064 ·Status: COMPLETED ·Phase: NA
-
Efficacy and Safety of Diclofenac Sodium (0.1%) Gel in Patients With UV Induced Painful Sunburn
NCT00441051 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Safety of Oral Isotretinoin for Cutaneous Photodamage
NCT00842907 ·Status: UNKNOWN ·Phase: PHASE2
-
A Study to Assess the Effectiveness of Sunscreen on Oil Control, Moisturization, and Skin Barrier Integrity in Adults With Oily Skin
NCT06616558 ·Status: COMPLETED ·Phase: NA
-
Clinical Study to Evaluate the Sun Protection Factor (SPF) of Three Sunscreen Products
NCT05109104 ·Status: COMPLETED ·Phase: NA
-
Photoprotection Efficacy of Different Topical Agents Under Visible Light Exposure
NCT06796153 ·Status: COMPLETED
-
Efficacy Study of a Novel Skin Health Product to Reduce an UVB Induced Erythema
NCT05300542 ·Status: COMPLETED ·Phase: NA
-
In-Use Tolerance & Efficacy Study Under Dermatological Control of Sunscreen in Adults With Atopic Dermatitis Skin
NCT07194421 ·Status: COMPLETED
-
Photoprotection Efficacy of a Sunscreen Under Visible Light Exposure by Using Two Different Simulators
NCT06796140 ·Status: COMPLETED
-
A Study to Assess the Safety and Efficacy of a Sunscreen on Acne-Prone Skin With Inflammatory and Non-Inflammatory Acne Vulgaris
NCT06544889 ·Status: COMPLETED ·Phase: NA
-
Performance of Different Application Regimens of ACTINICA® on Protection From UVR-induced Erythema After One Day of Sun Exposure in Fair-skinned Healthy Subjects.
NCT02251756 ·Status: COMPLETED ·Phase: NA
-
Photoprotection Efficacy With Sunscreen Formulas Containing the Cyclic Merocyanine Long-UVA Absorber MCE, Under Real Sun Exposure
NCT04865055 ·Status: UNKNOWN ·Phase: NA
-
Process Validation in Dermatology: Assessing Methods for UV Exposure (Artificial Source vs. Sunlight) and Efficacy Evaluation of Anti-Tanning Agents
NCT06384092 ·Status: COMPLETED ·Phase: NA
-
Prevention of UV-induced Carcinogenic Skin Alterations in Immunosuppressed Solid Organ Transplanted Patients
NCT01532453 ·Status: TERMINATED ·Phase: PHASE3